Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/μl

Objective: Lung cancer is the leading cause of non-AIDS-defining cancer deaths among HIV-infected individuals. Although lung cancer screening with low-dose computed tomography (LDCT) is endorsed by multiple national organizations, whether HIV-infected individuals would have similar benefit as uninfected individuals from lung cancer screening is unknown. Our objective was to determine the benefits and harms of lung cancer screening among HIV-infected individuals. Design: We modified an existing simulation model, the Lung Cancer Policy Model, for HIV-infected patients. Data sources: Veterans Aging Cohort Study, Kaiser Permanente Northern California HIV Cohort, and medical literature. Target population : HIV-infected current and former smokers. Time horizon : Lifetime. Perspective : Population. Intervention: Annual LDCT screening from ages 45, 50, or 55 until ages 72 or 77 years. Main outcome measures: Benefits assessed included lung cancer mortality reduction and life-years gained; harms assessed included numbers of LDCT examinations, false-positive results, and overdiagnosed cases. Results of base-case analysis: For HIV-infected patients with CD4+ cell count at least 500 cells/&mgr;l and 100% antiretroviral therapy adherence, screening using the Centers for Medicare & Medicaid Services criteria (age 55–77, 30 pack-years of smoking, current smoker or quit within 15 years of screening) would reduce lung cancer mortality by 18.9%, similar to the mortality reduction of uninfected individuals. Alternative screening strategies utilizing lower screening age and/or pack-years criteria increase mortality reduction, but require more LDCT examinations. Limitations: Strategies assumed 100% screening adherence. Conclusion: Lung cancer screening reduces mortality in HIV-infected patients with CD4+ cell count at least 500 cells/&mgr;l, with a number of efficient strategies for eligibility, including the current Centers for Medicare & Medicaid Services criteria.

[1]  Richard D Moore,et al.  Elevated incidence of lung cancer among HIV-infected individuals. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  R. Pfeiffer,et al.  Excess cancers among HIV-infected people in the United States. , 2015, Journal of the National Cancer Institute.

[3]  D. Origgi,et al.  Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis , 2017, British Medical Journal.

[4]  S. Crystal,et al.  Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. , 2009, AIDS education and prevention : official publication of the International Society for AIDS Education.

[5]  Melissa Skanderson,et al.  Development and Verification of a “Virtual” Cohort Using the National VA Health Information System , 2006, Medical care.

[6]  D. Klein,et al.  HIV infection and the risk of cancers with and without a known infectious cause , 2009, AIDS.

[7]  V. Moyer.  Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2014, Annals of Internal Medicine.

[8]  H. Katki,et al.  Cancer risk among the HIV-infected elderly in the United States , 2016, AIDS.

[9]  J. Goedert,et al.  Elevated risk of lung cancer among people with AIDS , 2007, AIDS.

[10]  Mark Roberts,et al.  Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value? , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[11]  K. Sigel,et al.  Lung Malignancies in HIV Infection , 2016, Seminars in Respiratory and Critical Care Medicine.

[12]  Richard D Moore,et al.  Prospective CT Screening for Lung Cancer in a High-Risk Population: HIV-Positive Smokers , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  Kathleen M. Akgün,et al.  Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening , 2014, AIDS.

[14]  G Scott Gazelle,et al.  Chapter 9: The MGH‐HMS Lung Cancer Policy Model: Tobacco Control Versus Screening , 2012, Risk analysis : an official publication of the Society for Risk Analysis.

[15]  B. Agan,et al.  The VACS Index Predicts Mortality in a Young, Healthy HIV Population Starting Highly Active Antiretroviral Therapy , 2014, Journal of acquired immune deficiency syndromes.

[16]  L. Pantanowitz,et al.  Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. , 2010, Clinical lung cancer.

[17]  J. Skarbinski,et al.  Cigarette Smoking Prevalence Among Adults With HIV Compared With the General Adult Population in the United States , 2015, Annals of Internal Medicine.

[18]  S. Cole,et al.  Lung Cancer Incidence and Mortality Among HIV-Infected and HIV-Uninfected Injection Drug Users , 2010, Journal of acquired immune deficiency syndromes.

[19]  B. Milleron,et al.  Lung cancer in HIV infected patients: facts, questions and challenges , 2006, Thorax.

[20]  Olivia Keiser,et al.  Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. , 2005, Journal of the National Cancer Institute.

[21]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[22]  H. Bradley,et al.  Increased antiretroviral therapy prescription and HIV viral suppression among persons receiving clinical care for HIV infection , 2016, AIDS.

[23]  S. Eymard-Duvernay,et al.  Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers , 2016, AIDS.

[24]  William Hazelton,et al.  Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force , 2014, Annals of Internal Medicine.

[25]  A. Justice,et al.  HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. , 2011, American journal of respiratory and critical care medicine.

[26]  C. Sigel,et al.  Prognosis in HIV-infected patients with non-small cell lung cancer , 2013, British Journal of Cancer.

[27]  Andrew J. Schaefer,et al.  Should Expectations about the Rate of New Antiretroviral Drug Development Impact the Timing of HIV Treatment Initiation and Expectations about Treatment Benefits? , 2014, PloS one.

[28]  S. Crystal,et al.  HIV as an independent risk factor for incident lung cancer , 2012, AIDS.

[29]  Division on Earth.  Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2 , 2006 .

[30]  D. Klein,et al.  Survival among HIV-Infected and HIV-Uninfected Individuals with Common Non–AIDS-Defining Cancers , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[31]  A. Phillips,et al.  Life expectancy living with HIV: recent estimates and future implications , 2013, Current opinion in infectious diseases.

[32]  David J Lee,et al.  Trends in Adherence to Recommended Cancer Screening: The US Population and Working Cancer Survivors , 2012, Front. Oncol..

[33]  James J. Goedert,et al.  Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada , 2013, PloS one.

[34]  B. Kramer,et al.  Overdiagnosis in low-dose computed tomography screening for lung cancer. , 2014, JAMA internal medicine.

[35]  D. Klein,et al.  Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care , 2016, Journal of acquired immune deficiency syndromes.

[36]  Summer S. Han,et al.  Comparing Benefits from Many Possible Computed Tomography Lung Cancer Screening Programs: Extrapolating from the National Lung Screening Trial Using Comparative Modeling , 2014, PloS one.

[37]  E. Simard,et al.  Cancer as a cause of death among people with AIDS in the United States. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  M. Edelman,et al.  Lung Cancer in HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[39]  M. Zwahlen,et al.  Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population , 2016, AIDS.

[40]  D. Vlahov,et al.  HIV infection is associated with an increased risk for lung cancer, independent of smoking. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  S. Preston‐Martin,et al.  Cancer Risk Among Participants in the Women’s Interagency HIV Study , 2004, Journal of acquired immune deficiency syndromes.

[42]  C. Katlama,et al.  HIV-Infected Adults With a CD4 Cell Count Greater Than 500 Cells/mm3 on Long-Term Combination Antiretroviral Therapy Reach Same Mortality Rates as the General Population , 2007, Journal of acquired immune deficiency syndromes.

[43]  Stephen J. Swensen,et al.  Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. , 2008, Radiology.

[44]  E. Engels,et al.  Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.